Your browser doesn't support javascript.
loading
Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry.
Theodorsdottir, Asta; Debrabant, Birgit; Magyari, Melinda; Kant, Matthias; Rasmussen, Peter V; Malmberg, Carl-Fredrik; Norberg, Iver A; Hansen, Victoria; Bech, Danny; Schmidt, Mathias F; Schreiber, Karen; Frederiksen, Jette L; Sellebjerg, Finn; Illes, Zsolt.
Afiliação
  • Theodorsdottir A; Department of Neurology, Odense University Hospital, Odense, Denmark/Department of Neurology, Hospital Lillebaelt, Kolding, Denmark/Institute of Clinical Research, University of Southern Denmark, Odense, Denmark/OPEN, Odense Patient Data Explorative Network, Odense University Hospital, Odense, Denma
  • Debrabant B; Department of Public Health, Epidemiology, Biostatistics & Biodemography, University of Southern Denmark, Odense, Denmark.
  • Magyari M; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark/The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.
  • Kant M; Department of Neurology, Hospital of Southern Jutland, Sønderborg, Denmark.
  • Rasmussen PV; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
  • Malmberg CF; Department of Neurology, Odense University Hospital, Odense, Denmark.
  • Norberg IA; Department of Neurology, Odense University Hospital, Odense, Denmark.
  • Hansen V; Department of Neurology, Aalborg University Hospital, Aalborg, Denmark.
  • Bech D; Department of Neurology, Regional Hospital of Viborg, Viborg, Denmark.
  • Schmidt MF; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.
  • Schreiber K; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.
  • Frederiksen JL; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.
  • Sellebjerg F; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark/The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.
  • Illes Z; Department of Neurology, Odense University Hospital, Odense, Denmark/Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Mult Scler ; 27(14): 2254-2266, 2021 12.
Article em En | MEDLINE | ID: mdl-33779361
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article